Investors Home  >  Investor Relations
Briefcase Printed Materials Email Alerts Download Center snapshot RSS

Investor Relations

Ticker: CNAT
6.43 (- 0.22)
Stock price graph

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Conatus Pharmaceuticals's financial performance into perspective.

View all »   RSSRecent Releases

Apr 8, 2015
Conatus Announces Completion of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Apr 8, 2015
Conatus Pharmaceuticals to Present Three Emricasan Clinical Results Posters at EASL Meeting

View all »Events & Presentations

Apr 15, 2015
14th Annual Needham Healthcare Conference
PDF View Presentation   2.2 MB   Add to Briefcase

Mar 23, 2015
54th Annual Meeting of the Society of Toxicology
PDF View Poster  158.6 KB   Add to Briefcase